Shares of ResMed Inc. RMD advanced 1.78% to $223.85 Monday, on what proved to be an all-around favorable trading session for ...

With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, ...

ResMed (NYSE:RMD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” ...

Thrivent Financial for Lutherans cut its stake in ResMed Inc. (NYSE:RMD – Free Report) by 0.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

ResMed RMD has achieved impressive growth over the past year, with its shares rallying 25.6%. It has outperformed the industry’s 13.1% rise and the S&P 500 composite’s 15.7% gain. Presently ...

A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive ...

Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly ...

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...

Morgan Stanley initiated coverage of ResMed (RMD) with an Overweight rating and A$313 price target The company has a market-leading position ...

Shares of ResMed Inc. RMD rose 1.46% to $222.91 Monday, on what proved to be an all-around great trading session for the ...